JENNIFER BROWN: Open Payments
NPI 1811585698 · SAN TAN VALLEY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$600 in 16 payments from 10 companies in 2025. Trend: 2023 $224 · 2024 $463 · 2025 $600
Food & beverage: $435Education: $165
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $243 |
| Regeneron Healthcare Solutions, Inc. | 1 | $98 |
| SANOFI-AVENTIS U.S. LLC | 1 | $67 |
| Verona Pharma, Inc. | 3 | $67 |
| United Therapeutics Corporation | 1 | $29 |
| Mallinckrodt Hospital Products Inc. | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Viatris Specialty LLC | 1 | $16 |
| Amgen Inc. | 1 | $15 |
| GENZYME CORPORATION | 1 | $14 |
Products named: DUPIXENT, AIRSUPRA, FASENRA, Ohtuvayre, Tyvaso, ACTHAR, TRELEGY ELLIPTA, YUPELRI.
Industry payments across AZ — which companies pay providers there.
